News stories about Symmetry Medical (NYSE:SMA) have trended somewhat positive on Wednesday, according to Accern Sentiment. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Symmetry Medical earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the healthcare company an impact score of 43.9944071978598 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://theolympiareport.com/2017/12/27/symmetry-medical-sma-given-daily-news-impact-rating-of-0-19-2.html.

Symmetry Medical Company Profile

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments).

Insider Buying and Selling by Quarter for Symmetry Medical (NYSE:SMA)

Receive News & Ratings for Symmetry Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symmetry Medical and related companies with Analyst Ratings Network's FREE daily email newsletter.